Phase II Study of Irinotecan in Combination With Capecitabine on a 3-Weekly Schedule As First-Line Chemotherapy for Patients With Metastatic or Locally Advanced Colorectal Cancer. J. Anal. Oncol. 2013, 2 (3),  151-159. https://doi.org/10.6000/1927-7229.2013.02.03.4.